Evidence map›Paper›PMID 24142591›Full record

ArticlePhytotherapy research : PTR2014

Panax notoginseng attenuates experimental colitis in the azoxymethane/dextran sulfate sodium mouse model.

Xiao-Dong Wen, Chong-Zhi Wang, Chunhao Yu, Lei Zhao, Zhiyu Zhang, Adiba Matin, Yunwei Wang, Ping Li, Shu-Yuan Xiao, Wei Du and 2 more

Abstract read
In one paragraph

Article in Phytotherapy research : PTR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. The application ofAnnals of translational medicine · 2025
    Review
  2. Article
  3. Article
  4. The potential ofJournal of ginseng research · 2023
    Review
  5. Article
  6. Review
  7. The Effects of Berberine on the Gut Microbiota in ApcMolecules (Basel, Switzerland) · 2018
    Article
  8. Article
  9. Article
  10. Evidence-based complementary and alternative medicine : eCAM · 2018
    Article
  11. Effects of initiating time and dosage ofWorld journal of gastroenterology · 2017
    Article
  12. Article
  13. Article
  14. Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2017
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Xiao-Dong WenTang Center for Herbal Medicine Research, University of Chicago, Chicago, IL, 60637, USA; Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL, 60637, USA; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 210009, China.
Chong-Zhi Wang
Chunhao Yu
Lei Zhao
Zhiyu Zhang
Adiba Matin
Yunwei Wang
Ping Li
Shu-Yuan Xiao
Wei Du
Tong-Chuan He
Chun-Su Yuan
University of Chicago · USChina Pharmaceutical University · CN

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Center for Herbal Research on Colorectal CancerP01AT004418 · NCCIH · UNIVERSITY OF CHICAGO · PI YUAN, CHUN-SU · 2008 to 2012
$5.9M
Chemoprevention of Active Scutellaria baicalensis Fraction on Colon CancerK01AT005362 · NCCIH · UNIVERSITY OF CHICAGO · PI WANG, CHONG-ZHI · 2010 to 2014
$486k
NCATS NIH HHS UL1 TR000430NCCIH NIH HHS K01 AT005362NCCIH NIH HHS P01 AT004418
6 · The paper itself

Abstract

Patients suffering from inflammatory bowel disease are at a high risk of developing colorectal cancer. To assess the anticancer potential of botanicals, in this study, we evaluated the effects of Panax notoginseng on azoxymethane/dextran sulfate sodium (DSS)-induced colitis. One week after A/J mice received azoxymethane, the animals received DSS for 8 days or were supplemented with P. notoginseng extract, at 30 or 90 mg/kg. DSS-induced colitis was scored with the disease activity index. The severity of the inflammatory lesions was evaluated by a colon tissue histological assessment. The expression of inducible nitric oxide synthase and cyclooxygenase-2 (COX-2) were also explored. We observed that the effects of P. notoginseng on the reduction of colon inflammation, expressed in disease activity index score, were in a dose-related manner (p < 0.01). P. notoginseng inhibited the reduction of the colon length and the loss of bodyweight in dose-related manner (all p < 0.05). The histological assessment of the colitis and inflammatory-related immunohistochemical data also supported the pharmacological observations. Our data suggest that P. notoginseng is a promising candidate in preventing and treating colitis and inflammation-associated colon carcinogenesis.

Indexed as

AnimalsAzoxymethaneColitisColonCyclooxygenase 2Dextran SulfateDisease Models, AnimalMaleMiceNitric Oxide Synthase Type IIPanax notoginsengPlant ExtractsSaponinsAzoxymethaneCyclooxygenase 2Dextran SulfateNitric Oxide Synthase Type IINos2 protein, mousePlant ExtractsPtgs2 protein, mouseSaponinsAOM/DSS modelcolitiscolorectal carcinogenesisinflammatory bowel diseasenotoginsengPanax notoginseng

Identifiers

PMID24142591
PMCPMC3994185
OpenAlexW1822707923

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.